Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06602024
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-15
Brief Title:
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults 50 Years of Age
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 3 Randomized Observer-blind Active-controlled Case-driven Study to Investigate the Safety Efficacy and Immunogenicity of mRNA-1010 Candidate Seasonal Influenza Vaccine Compared With a Licensed Inactivated Seasonal Influenza Vaccine in Adults 50 Years of Age
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1010 and to evaluate relative vaccine efficacy rVE of mRNA-1010 versus an active comparator against protocol-defined influenza-like illness ILI caused by any influenza A or B strains
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None